High Vista Strategies LLC Vbi Vaccines Inc Transaction History

High Vista Strategies LLC

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 14, 2022	SELL	$2.21 - $3.22 $91,208 - $132,892	-41,271 Closed	0 $0
Q3 2021 Nov 15, 2021	BUY	$2.8 - $3.72 $35,478 - $47,136	12,671 Added 44.3%	41,271 $129,000
Q3 2020 Nov 16, 2020	BUY	$2.77 - $6.17 $79,222 - $176,462	28,600 New	28,600 $82,000

688K

Ticker VBIV
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 258,256,992
Market Cap $5.17M
Description
VBI Vaccines Inc., a biopharmaceutical company, develops and sells vaccines for the treatment of infectious diseases and immuno-oncology. The company offers Sci-B-Vac, a prophylactic hepatitis B (HBV) vaccine. It also engages in the development of VBI-2601 (BRII-179), an immunotherapeutic candidate for the treatment of chronic HBV infection. The...

Get notified when there are updates to the investment portfolio of High Vista Strategies LLC, based on Form 13F filings with the SEC.

Stay updated on High Vista Strategies LLC with notifications on news.